149 related articles for article (PubMed ID: 28597077)
1. Is Rosai-Dorfman disease a reactve process? Detection of a MAP2K1 L115V mutation in a case of Rosai-Dorfman disease.
Matter MS; Bihl M; Juskevicius D; Tzankov A
Virchows Arch; 2017 Oct; 471(4):545-547. PubMed ID: 28597077
[No Abstract] [Full Text] [Related]
2. Pediatric recurrent Rosai-Dorfman disease with germline heterozygous SLC29A3 and somatic MAP2K1 mutations.
Suryaprakash S; George A; Langenburg S; Savaşan S
Ann Hematol; 2020 Dec; 99(12):2965-2967. PubMed ID: 32944792
[No Abstract] [Full Text] [Related]
3. Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease.
Garces S; Medeiros LJ; Patel KP; Li S; Pina-Oviedo S; Li J; Garces JC; Khoury JD; Yin CC
Mod Pathol; 2017 Oct; 30(10):1367-1377. PubMed ID: 28664935
[TBL] [Abstract][Full Text] [Related]
4. MAP2K1-driven mixed Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease and Erdheim-Chester disease, clonally related to acute myeloid leukemia.
Bonometti A; Ferrario G; Parafioriti A; Giardino D; Simonetti F; Ginori A; Passoni E; Berti E;
J Cutan Pathol; 2021 May; 48(5):637-643. PubMed ID: 33188581
[TBL] [Abstract][Full Text] [Related]
5. Rosai-Dorfman Disease Harboring an Activating KRAS K117N Missense Mutation.
Shanmugam V; Margolskee E; Kluk M; Giorgadze T; Orazi A
Head Neck Pathol; 2016 Sep; 10(3):394-9. PubMed ID: 26922062
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous Rosai Dorfman disease harboring RET and MAP2K1 mutations, successfully treated with methotrexate.
Konstantinou MP; Tournier E
Int J Dermatol; 2022 Nov; 61(11):1409-1411. PubMed ID: 35569068
[No Abstract] [Full Text] [Related]
7.
Fatobene G; Haroche J; Hélias-Rodzwicz Z; Charlotte F; Taly V; Ferreira AM; Abdo ANR; Rocha V; Emile JF
Haematologica; 2018 Aug; 103(8):e377-e379. PubMed ID: 29748446
[No Abstract] [Full Text] [Related]
8. Emperipolesis: an additional common histopathologic finding in H syndrome and Rosai-Dorfman disease.
Colmenero I; Molho-Pessach V; Torrelo A; Zlotogorski A; Requena L
Am J Dermatopathol; 2012 May; 34(3):315-20. PubMed ID: 22356918
[TBL] [Abstract][Full Text] [Related]
9. Rosai-Dorfman Disease with Activating KRAS Mutation - Response to Cobimetinib.
Jacobsen E; Shanmugam V; Jagannathan J
N Engl J Med; 2017 Dec; 377(24):2398-2399. PubMed ID: 29236635
[No Abstract] [Full Text] [Related]
10. Generalized pure cutaneous Rosai-Dorfman disease: a link between inflammation and cancer not associated with mitochondrial DNA and SLC29A3 gene mutation?
Zheng M; Bi R; Li W; Landeck L; Chen JQ; Lao LM; Cai SQ; Yao YG; Man XY
Discov Med; 2013 Nov; 16(89):193-200. PubMed ID: 24229736
[TBL] [Abstract][Full Text] [Related]
11. Rosai-Dorfman Disease and Exocrine Pancreatic Insufficiency in a Patient With a Germline SLC29A3 Mutation.
Blatt J; Parekh P; Powell BC; Fedoriw Y; Reddy I; Montgomery ND
J Pediatr Hematol Oncol; 2021 Jul; 43(5):e689-e691. PubMed ID: 32769566
[TBL] [Abstract][Full Text] [Related]
12. Redefining the Prevalence of Dural Involvement in Rosai-Dorfman Disease of the Central Nervous System.
Hong CS; Starke RM; Hays MA; Mandell JW; Schiff D; Asthagiri AR
World Neurosurg; 2016 Jun; 90():702.e13-702.e20. PubMed ID: 26968450
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous Rosai-Dorfman disease: comprehensive review of cases reported in the medical literature since 1990 and presentation of an illustrative case.
Frater JL; Maddox JS; Obadiah JM; Hurley MY
J Cutan Med Surg; 2006; 10(6):281-90. PubMed ID: 17241598
[TBL] [Abstract][Full Text] [Related]
14. Rosai-Dorfman Disease Isolated to the Thoracic Epidural Spine.
Kozak B; Talbott J; Uzelac A; Rehani B
J Radiol Case Rep; 2015 Nov; 9(11):6-16. PubMed ID: 27252790
[TBL] [Abstract][Full Text] [Related]
15. Rosai-Dorfman disease (extranodal sinus histiocytosis) in a patient with HIV.
Perry BP; Gregg CM; Myers S; Lilly S; Mann KP; Prieto V
Ear Nose Throat J; 1998 Oct; 77(10):855-8. PubMed ID: 9818538
[TBL] [Abstract][Full Text] [Related]
16. Erdheim-Chester disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by
Razanamahery J; Diamond EL; Cohen-Aubart F; Plate KH; Lourida G; Charlotte F; Hélias-Rodzewicz Z; Goyal G; Go RS; Dogan A; Abdel-Wahab O; Durham B; Ozkaya N; Amoura Z; Emile JF; Haroche J
Haematologica; 2020 Jan; 105(1):e5-e8. PubMed ID: 31123032
[No Abstract] [Full Text] [Related]
17. Sinus histiocytosis with massive lymphadenopathy: a "massive" misnomer.
Sardana D; Goyal A; Gauba K
Diagn Cytopathol; 2015 Apr; 43(4):315-9. PubMed ID: 25088489
[TBL] [Abstract][Full Text] [Related]
18. A rare case of extranodal Rosai-Dorfman disease.
Chopra D; Svensson WE; Forouhi P; Poole S
Br J Radiol; 2006 Oct; 79(946):e117-9. PubMed ID: 16980664
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous Rosai-Dorfman disease: presenting as massive bilateral eyelid swelling.
Jat KR; Panigrahi I; Srinivasan R; Singh U; Vasishta RK; Sharma N; Duggal R; Marwaha RK
Pediatr Dermatol; 2009; 26(5):633-5. PubMed ID: 19840336
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous involvement of pre-existing Rosai-Dorfman disease via post-herpetic isotopic response.
Malviya N; Marzuka A; Maamed-Tayeb M; Le L; Vandergriff T
J Cutan Pathol; 2016 Dec; 43(12):1211-1214. PubMed ID: 27611178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
